Samsung Biologics has launched "Samsung Organoids," a drug screening service using organoid technology, aiming to accelerate anticancer drug development and expand its portfolio amid global market growth and regulatory support.
#YonhapInfomax #SamsungBiologics #Organoids #DrugScreening #FDA #MarketGrowth #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=67622